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Abstract: The need for new and effective/efficient antibacterial therapeutics and diagnostics is necessary if we want to be 
able to maintain and improve the protection against pathogenic bacteria. Bacteria are becoming increasingly resistant to 
traditionally used antibiotics and as a result are a major health concern. The number of deaths and hospitalizations due to 
bacteria is increasing. Current methods of bacterial diagnostics are inefficient as they lack speed and ultra sensitivity and 
cannot be performed on site. This is where nanomedicine is playing a vital role. The discovery of new and innovative 
materials through the improvement in fabrication techniques has seen the establishment of an influx of novel antibacterial 
therapeutics and diagnostics. The goal of this review is to highlight the research that has been done through the 
implementation of nanomaterials and nanotechnologies for antibacterial medical therapeutic and diagnostic.  
INTRODUCTION 
 Pathogenic bacteria remain a major health concern, 
which are responsible for causing a large number of deaths 
and hospitalizations each year. Although we have current 
treatments such as antibiotics, bacteria are gaining resistance 
to these therapeutics at an alarming rate. That is why new 
therapeutic and diagnostic treatments are necessary if we 
want to be prepared against known and unknown pathogenic 
bacterial infections. A range of potential solutions have been 
researched in hope that new treatments and diagnostic 
techniques will be developed. A large group of these studies 
includes the implementation of nanotechnologies and nano-
materials to create new antibacterial nanomedicines that 
increased effectiveness and efficiency
 
[1,2]. Nanome-dicine 
is defined as the monitoring, repair, construction and control 
of human biological systems at the molecular level, using 
engineered nanodevices and nanostructures. This is the field 
of science and technology for diagnosing, treating and 
preventing disease and traumatic injury, of relieving pain, 
and of preserving and improving human health, using 
molecular tools and molecular knowledge of the human 
body. Nanotechnology is the area of science which deals 
with developing and producing extremely small tools and 
machines by controlling the arrangement of individual atoms 
thorough, inexpensive control of the structure of matter 
based on molecule-by-molecule control of products and by- 
products; the products and processes of molecular manufac- 
turing, including molecular machinery. This review looks at 
a range of new potential antibacterial therapeutics and 
diagnostics which implements nanotechnology, most of 
which are in early stages of research but has already shown 
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positive signs of application into nanomedical therapeutics 
and diagnostics. With the use of new novel materials and 
technologies it seems that we will be able to create new 
antibacterial therapeutics that are more effective in combina-
tion with rapid and ultra sensitive bacterial diagnostics, 
which will hopefully allow us to obtain further protection 
against harmful bacteria. Nanocarriers have provided a novel 
platform for target-specific delivery of therapeutic agents. 
Over the past decade, several delivery vehicles have been 
designed based on different nanomaterials, such as polymers, 
dendrimers, liposomes, nanotubes, and nanorods. These 
nanoparticles have recently emerged as an attractive candi-
date for delivery as well as for diagnosis [1-6]. 
 In this review we will write the comparative and 
systematic studies on nanotechnology based therapeutics and 
diagnostics on pathogenic bacteria which will give a 
complete picture of nanomedicine to researchers, patients 
and clinicians on treatments and diagnosis. This review will 
give new growing prospective for improving disease mana-
gement and control in the future.  
THERAPEUTICS 
Synthetic Antibacterial Nanomedicines 
Carbon Nanotubes and Fullerenes  
 Since the discovery of carbon nanotubes they have 
flourished and have been applied in a broad range of areas in 
science and in a way represent the momentum of 
nanotechnology itself. They have been sourced due to their 
unique optical, thermal, magnetic, high strength properties as 
well as the ability to be conductive, almost all of which can 
be tuned depending on the dimensions of the nanotube (Fig. 
1). As of late they have been used in medical research in 
applications such as drug delivery and as components in  
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Fig. (1). The structures of (A) A single-walled nanotube (B) A 
fullerene [1, 2]. 
 
medical nanodevices. They have also been noted for their 
apparent toxicity to biological systems, as they themselves 
are so small that they act like fibers, and have the same 
toxicological impacts of other known toxic fibers, for 
example asbestos. A recent study was performed that looked 
into the antimicrobial properties of carbon nanotubes and 
showed that they are strong antibacterial agents [2]. The 
study conducted by Kang used low metal content, well 
characterized, narrowly distributed, pristine Single walled 
nanotubes (SWNTs), which are to observe bactericidal 
activity on the bacterium Escherichia coli K12. The bacteria 
were incubated with the SWNTs for 60-mins and microbial 
viability was checked and showed that over 80% of the 
microbes were killed. The suggested mode of death was the 
direct interaction of the SWNTs with the bacterial cell 
membranes causing significant membrane damage [7]. 
Similar research using nanotubes of different materials such 
as peptides and lipids also have shown the same mode of 
toxicity on microbes, suggesting that the nanotubes are able 
to physically penetrate the cell membranes to their physical 
dimensions leading to cell death [8]. Fullerene C60 is another 
carbon structure that has been investigated as an antimic-
robial agent, as a means of identifying environmental 
impacts of fullerene C60. Research was conducted to test the 
toxicity of the fullerene molecules on two species of 
bacteria, E.coli DH5 and Bacillus Subtilis, the former being 
a gram negative and the latter being gram positive [9]. The 
study showed that the fullerenes did act as bactericidal 
agents on both bacteria types, but it was also identified that 
differences in physical dimension of fullerene C60 types have 
alternative effects therefore more specific testing would be 
required [9].  
Silver Nanoparticles  
 Silver has long been used in medicine, even in ancient 
times it was used as a preservative and also to reduce 
inflammation and prevent against infection of wounds [10]. 
It is due to this prior knowledge that further studies using 
silver as antibacterial agents has been perused, and bulk 
silver has already been used in appliances that are prone to 
microbial contamination, such as a fridge with an internal 
silver lining that was developed by LG (www.lge.com). With 
the development of more advanced materials and advanced 
fabrication techniques, nano sized materials can be easily 
produced, and differ from their macro counterparts, exhi-
biting new and enhanced properties. Silver is no exception, 
scaling down silver to the nanoscale provides a higher 
specific surface area and a higher fraction of surface atoms 
that improves its antimicrobial activity compared with bulk 
silver. A study was performed to test the effectiveness of 
silver nanoparticle antimicrobial activity using E .coli was 
undertaken by a Sonda [11]. In the study 10
5
 CFU of gram 
negative E. coli colonies were grown on LB agar plates with 
different concentrations of Ag-nanoparticles. Ag-NPs at 
concentrations of 10 g cm –3 showed inhibition of bacterial 
growth by up to 70%, and at concentrations of 50-60 g cm -
3
 there was 100% inhibition of bacterial growth [12]
.
 A SEM 
and TEM analysis showed the accumulation of the 
nanoparticles within membranes and some were able to 
penetrate into the cell, the SEM also highlights the damage 
caused by the Ag-NPs where visible “pits” can be observed.  
 Silver ions antimicrobial activity is believed to work by 
impairing DNAs ability to replicate and through the 
inactivation of key proteins by denaturation when they are 
bound together [11]. Although it is still unknown what type 
of interaction takes place between the nanoparticles and the 
constituents of the outer membrane. Another study showed 
that with the use of silver nanoparticles in conjunction with 
antibiotics such as penicillin G, amoxicillin, erythromycin, 
clindamycin and vancomycin, provided an increase in the 
effectiveness of the antibiotics [12]. Silver nanoparticles 
show great potential as antimicrobial agents in applications, 
as they are of low cost and easily synthesized, and could be 
used to treat material surfaces to provide highly effective 
antibacterial materials, medical equipment such as in and 
devices and paints.  
Bioactive Glasses  
 Bioactive glasses are a group of novel new materials that 
have been researched due to their interesting characteristics, 
and have already been used in clinical environments such as 
a disinfectant in dentistry. There is a range of different 
bioactive glasses but only one has been approved by FDA, 
known as 45S5 and is composed of SiO2-Na2O-CaO-P2O5, 
and is currently used in dentistry [13]. It is well known that 
bioactive glasses in a solution exhibit a mild antimicrobial 
activity, due to the release of their ionic compounds and 
intake of H3O
+
 protons it is able alter the local environment 
by increasing alkalinity of the solution. This in turn disrupts 
bacteria that are tolerant to the high-pH change. A study was 
conducted by Waltimo
 
[13] to test if the hypothesis that 
nanometric bioactive glass should have a greater antimi-
crobial activity than when compared with regular bioactive 
glasses due to a higher specific surface area, which in turn 
results in more alkaline species being released. It was shown 
that the nanoparticulate 45S5 was able to kill 99% of the 
bacteria, which in this case was E.Faecalis when incubated 
in simulated body fluid for 100 minutes. It was also shown 
that the pH of the 45S5 nanoparticulate supernatant was 11.7 
which closely coincide with calcium hydroxide which is the 
most commonly used disinfectant in dentistry’s today. 
Bioactive glasses show promise as an effective antimicrobial 
agent that could be applied to dentistry as well as other 
clinical environments that require sterile equipments and 
settings [13].  
Metal Oxide Nanoparticles  
 Metal oxide nanoparticles represent a new class of 
important materials that are increasingly being developed for 
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use in research and medical applications, due to their 
desirable varying physical and chemical properties and also 
the apparent antibacterial activity. In this review only a 
handful of the metal oxides will be examined, but there are 
many more that have also been shown to exhibit 
antimicrobial properties [14-18].  
Magnesium Oxide Nanoparticles  
 Nano-MgO has been involved in many different areas of 
research due to its novel properties, particularly in 
nanocomposite materials but now has been approached as 
antibacterial agents. MgO was originally known to be an 
antibacterial agent and it was thought that the damage caused 
to bacteria was due to the formation of superoxide anions on 
its surface; this inspired further research into understanding 
the mode of action that allows nano-MgO to exhibit 
antibacterial activity [14]. It was found that nano-MgO 
particles are able to take up halogen gases due to its 
defective natured surface and its positive charge, which 
results in a strong interaction with bacteria and spores as 
they are negatively charged. In this study the nano-MgO 
particles were produced and bromide and chloride were 
absorbed into the particles and then tested against E. coli, B. 
cereus and B. globigii as well as the spores from the Bacillus 
species. Experimental results showed that nano-MgO in 
conjunction with the uptake of halogens, in particular 
chloride, that effective destruction of the bacteria and 
bacterial spores was observed [14]. Another study was 
conducted which also covered the antimicrobial properties of 
nano-MgO and showed highly controlled synthesis of the 
particles with the ability to control particle size [15]. 
Through this process, using a range of Nano-Mg particle 
sizes ranging from 70nm down to around 8nm, it was a 
observed that there was significant antimicrobial activity that 
actually increased the with a decrease in particle size, in 
particular with B.subtilis [15]. Nano-MgO has a great 
potential to be used as an antimicrobial agent, and probably 
more so than other metal-oxide nanoparticles showing 
antimicrobial activity due to the lack of required light that is 
necessary for other metal oxides to function, as well as the 
benefit of being non-toxic. It has been tested already in 
Phenylpropyl type interior paints and shown significant 
antimicrobial activity, this type of application could be 
applied in many medical facilities as well as households as a 
means to reduce contamination and pathogenesis to humans 
[15]
.
 
Zinc Oxide Nanoparticles  
 It is known that zinc oxide exhibits antibacterial activity 
like many other metal oxide groups and like the others only 
few have been scaled down to the nano size and researched 
further, such as ZnO nanoparticles. It has been shown that 
ZnO nanoparticles show significant antibacterial activity 
over a broad range of bacterial species and in particular 
against Staphylococcus aureus where it out competes five 
other commonly used metal oxide nanoparticles [16]. 
Research that was carried out by Jones [16] to test the 
antibacterial activity of nanoparticles as well as the impact of 
particle size on bactericidal efficiency. In the experiment 
they used four different bacteria species, which included  
 
Staphylococcus aureus N315, Staphylococcus epidermidis 
1487, Streptococcus pyogenes NZ131 and Bacillus subtilis, 
as well as testing four different ZnO particle concentrations 
of 0mM, 2mM, 5mM and 10mM. The results showed a 
significant loss in viable cell numbers of all four bacteria 
species, with 5mM and 10mM being the most effective and 
2mM being the worst, where it provided only a slight 
improvement from the control [11]. The effect of particle 
size was also tested using three different sized ZnO particles. 
Sizes used were  1 m, 50-70nm and 8nm, and were 
tested on staphylococcus aureus. Results showed that the 
smaller particle sizes were able to reduce bacterial growth in 
some cases up to 99% while the larger particles for the same 
conditions only managed 40 – 50% inhibition of bacterial 
growth [16]. There is range of potential antibacterial 
applications for ZnO nanoparticles to be implemented into 
such as ointments, surface coatings, disinfectants for 
dentistry and in medical facilities.  
Silicon Dioxide Nanoparticles  
 SiO2 is used very extensively in material sciences and has 
also been more recently used in a range of medical research 
such as drug delivery [17]. Nano-SiO2 is not used directly as 
an antimicrobial agent itself but acts as a carrier for 
antimicrobial and bactericidal agents due to its exceptionally 
porous structure. Due to this porous structure SiO2 is able to 
absorb ions and organic molecules quite easily, making it 
highly efficient and a promising carrier for antimicrobial 
applications. As observed in previous examples in this 
review, metal- containing inorganic materials has shown to 
be effective as antimicrobial agents; therefore a study was 
conducted and has implemented zinc and silver into SiO2 
nanoparticles as a means of creating a high-performance 
bactericidal agent [18]. In the experiment conducted by a Jia 
[18] they synthesized two different types of SiO2 particles 
one that has been loaded with silver cations known as SLS 
and a co-absorption of zinc-silver loaded into the other, titled 
SLSZ. The SiO2 particles were around 20nm ± 5nm in size 
and composed of 0.5 % Ag
+
 and 4-9% of Zn
2+ 
in the SLZS 
with the amount of silver ions evenly distributed in each of 
both SLS and SLZS. The nanoparticles were tested on two 
bacteria species being E.coli and Streptococcus faecalis and 
were incubated with two singular concentrations of 2.5mg 
and 5mg for both SLS and SLZS. The results showed that 
both SLS and SLZS exhibit excellent antibacterial activity, 
for both E. coli and S. faecalis. SLS was able to kill all the 
viable E. coli cells after a contact time of 6hrs when 2.5mg 
was used and was brought down to 4hrs when 5.0mg of the 
loaded nanoparticles were used. Likewise, the SLZS was 
able to decrease the contact time needed even further 
reducing it from 4hrs to 2hrs. Results using S. faecalis 
produced were just as promising, with SLS able to kill all 
viable cells after an incubation period of 10hrs using 2.5mg 
and down to 6hrs using 5.0mg. Respectively for the SLZS 
particles the incubation time needed to kill all the viable cells 
was brought down from 6hrs using the 2.5mg to 2hrs using 
the amount of 5.0mg. SLZS was noticeably the more 
effective of the two, which is believed to be due to an 
increase in antibacterial sites enhancing the contact of the 
particles with the bacteria so the process speed was 
increased.  
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Biological Based Antibacterial Nanomedicines 
Chitosan Nanofiber  
 Chitosan is a polysaccharide that is found in the exoske-
leton of crustaceans and used in a range of commercial and 
biomedical applications such as a plant growth enhancer and 
even as a blood clotting agent [19]. But a recent study by 
Ignatova [20] has been carried out using Chitosan to create 
electrospun nano-fiber mats that have antibacterial activity. 
The experiment involves creating fibers in the range of 60-
200nm out of quaternized Chitosan (QCh) mixed with poly 
(vinyl alcohol) (PVA) and were stabilized successfully 
against dissolution in the aqueous environment using photo-
mediated cross-linking. The bactericidal ability of the QCh 
mats is due to the damaging interaction of polycations with 
the negatively charged surface of bacteria which results in 
the loss of bacterial membrane permeability, cell leakage and 
eventually cell death. The effectiveness of the QCh mats was 
tested on S. aureus and E. coli. The mats were more effective 
against the gram-negative S. aureus, with all viable bacteria 
being killed after an incubation period of 60 minutes, while 
the gram-positive E. coli were destroyed after 120 minutes. 
The results highlight the potential of electrospun mats to be 
used for wound-dressings as they are able to reduce the 
threat of secondary infection by bacteria. Additional chitosan 
also provides all the desirable properties that are required for 
fast wound healing that is non-toxic, has hemostatic activity, 
biodegradability and the ability to affect macrophage 
function [20].  
Targeted Drug-Carrying Phage Medicines 
 Various specific indicator cultures were tested for 
providing clear plaques after phage infection. Specific lytic 
mixture of bacteriophages was prepared using the induced, 
modified and laboratory variants of phages in the past [21-
26]. There are currently many highly antibacterial agents that 
have been developed but due to the lack of selectivity they 
are too potent to be used clinically. A way to overcome this 
shortcoming is to increase the selectivity of the agent by 
targeted therapy which is indeed what a group of researchers 
have accomplished. Yacoby [21]
 
has devised an efficient 
targeted drug platform to address the requirements of 
targeted drug delivery, in that it is able to selectively bind to 
its target, provide large drug delivery payload and timely 
drug release.
 
Their approach to such criteria was in the 
development of a drug-carrying phage nanoparticle that was 
successfully able to inhibit the growth of both gram-negative 
and gram-positive bacteria [20]. A phage was used as the 
drug-carrier as it has nanometric parameters that offer a 
unique and excellent drug-carrying ability, when compared 
to other particle drug-carrying devices that are commonly 
used such as liposomes or virus-like particles [19, 20]. This 
feature was also enhanced by use of clever chemistry 
through the introduction of amino sugar-based aminogly-
cosides as branched, hydrophilic linkers. This addition 
enabled two added benefits that are essential to the criteria 
required for a targeted drug carrying system, firstly 
providing the salvation of hydrophobic materials, which in 
this case is the drug chloramphenicol. This in turn enables a 
far greater uptake of the drug to the phage in aqueous 
solution, while also increasing the drug-carrying capacity of  
 
the phages from around 3000 molecules of chloramphenicol/ 
phage to 40,000
 
[20]. The targeting system uses microbe –
specific polyclonal antibodies that target a broad range of 
pathogenic bacterium. In this experiment they tested the 
drug-carrying phage nanoparticles against three pathogenic 
bacteria, which included staphylococcus aureus, streptoco-
ccus pyogenes and E.coli. Through this they were able to 
achieve complete growth inhibition towards all three 
bacterium and are comparable to using the free drug itself, 
resulting in an improvement factor of 20,000 compared with 
the free drug alone [21]. 
Poly-L-Lactide Nanoparticles  
 Nisin is an antimicrobial protein produced by 
Lactococcus lactis and is known as a lantinobiotic due to the 
fact that it contains unusual amino acids such as lanthionine 
[27]. Nisin has just recently been approved by the FDA for 
use as a food additive to provide preservation due to its 
broad spectrum antibacterial activity against gram-positive 
bacteria. One major problem when implementing nisin as a 
food additive is due to its weak structural integrity and 
certain bacteria having a minor tolerance to its effects, hefty 
amount of nisin is required. But it has now been combined 
with the use of Poly-Lactide nanoparticles in a study by 
Salmaso [27]. Poly-L-Lactide was used as it is biodegradable 
and nontoxic and could be used in certain applications of 
interest, as well as being easily producible. The nisin loaded 
poly-L-lactide nanoparticles were produced using a mixed 
solvent method implementing super critical CO2, and 
particles were shown to be of low diameter, low dispersity 
and were capable of loading high protein quantities. The 
average particle size was found to be between 250 – 400nm. 
They were then tested for their antibacterial properties 
against Lactobacillus using two nisin loaded concentrations 
of 20mg of a 5% and 20mg of 20% nisin loaded particle. 
Results of the experiment showed a significant improvement 
in the antibacterial activity time compared with the free 
nisin, with free nisin being active for around 7 days to an 
increased 40 days with the use of the nisin loaded in the 
poly-L-lactide nanoparticles. There is a considerable 
potential for this technique in protein formulation as shown 
by the nisin loaded poly-L-lactide nanoparticles, with obser-
ved results demonstrating improved protein stabilization and 
prolonged antibacterial activity, thus allowing such a 
compound to be applied in food and pharmaceutical preser-
vation [27]. There have also been similar studies conducted 
using biodegradable polymers in conjunction with anti-
bacterial agents with similar results observed. For example a 
study using poly Lactide-co-glycolide nanoparticles loaded 
with rifampicin is also an antimicrobial protein that 
originates from bacteria [28]. 
DIAGNOSTICS 
 Nonspecific and nonsensitive medical diagnosis 
problems are a quest of all civilizations. Nanoscience is one 
of the major areas of present scientific progress and should 
shortly result in essential advancement for the benefit of 
human health. The biomedical applications of metal nano-
particles started in the 1970s with the use of nanobiocon-
jugates after the discovery of immunogold labeling by Faulk  
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and Taylor [28]. Nanotechnology has brought a key contri-
bution, a crucial property being the plasmon absorption and 
scattering of gold nanoparticles. In this review, we will 
concentrate our attention on gold nanoparticles, quantum 
dots, dye-doped fluorescent silica nanoparticles and carbon 
tubing.  
Gold Nanoparticles 
 Nanodiagnostics can be defined as the use of nano-sized 
materials, devices or systems for diagnostics purposes. It is a 
burgeoning field as more and improved techniques are 
becoming available for clinical diagnostics with increased 
sensitivity at lower cost. The impact of advances in nano-
technology is particularly relevant in biodiagnostics, where 
nanoparticle-based assays have been developed for specific 
detection of bioanalytes of clinical interest. Gold nanopar-
ticles show easily tuned physical properties, including 
unique optical properties, robustness, and high surface areas, 
making them ideal candidates for developing biomarker 
platforms. Modulation of these physicochemical properties 
can be easily achieved by adequate synthetic strategies and 
provides gold nanoparticles advantages over conventional 
detection methods currently used as a in the clinical 
diagnostics. The surface of gold nanoparticles can be tailored 
by ligand functionalization to selectively bind biomarkers. 
Thiol-linking of DNA and chemical functionalization of gold 
nanoparticles for specific protein/antibody binding are the 
most common approaches [28-30]. Gold nanoparticles used 
as basis for the development of methodologies suitable for 
application in clinical diagnosis with three different appro-
aches; 1) utilization of the gold nanoparticles when color 
change upon aggregation, the best characterized example of 
being gold nanoparticles functionalized with ssDNA capable 
of specifically hybridizing to a complementary target for the 
detection of specific nucleic acid sequences in biological 
samples; 2) use of gold nanoparticles as a core/seed that can 
be tailored with a wide variety of surface functionalities to 
provide highly selective nanoprobes for diagnosis; and 3) 
utilization of AuNPs in electrochemical based methods that 
can be coupled with metal deposition for signal enhance-
ment. The latest approaches were recently reviewed in 
details [30-32]. These critical reviews provide an overall 
survey of the basic concepts and up-to-date literature results 
concerning the very promising use of gold nanoparticles 
(AuNPs) for medicinal applications. It includes AuNP 
synthesis, assembly and conjugation with biological and 
biocompatible ligands, plasmon-based labeling and imaging, 
optical and electrochemical sensing, diagnostics, therapy 
(drug vectorization and DNA/gene delivery) for various 
diseases, in particular cancer (also Alzheimer, HIV, hepatitis, 
tuberculosis, arthritis, diabetes) and the essential in vitro and 
in vivo toxicity. Gold nanoparticles exploit their unique 
chemical and physical properties for transporting and 
unloading the pharmaceuticals. First, the gold core is 
essentially inert and non-toxic. A second advantage is their 
ease of synthesis; monodisperse nanoparticles can be formed 
with core sizes ranging from 1 nm to 150 nm. Further 
versatility is imparted by their ready functionalization, 
generally through thiol linkages (vide post). Moreover, their 
photophysical properties could trigger drug release at remote 
place
 
[30-32]. 
Quantum Dots 
 Quantum dots seem to be very promising for a range of 
different applications, particularly in medical diagnostics. 
Most of the research focus has been on the implementation 
of quantum dots in diagnostics of cancers and microarray 
technologies, but research has also been conducted on using 
quantum dots as the components of an effective bacterial 
diagnostic system. Quantum dots (QDs) are semiconducting 
crystals such as CdSe, CdTe, CdS, ZnSe, PbS and PbTe that 
typically have diameters that range between 2nm and 10 nm. 
QDs exhibit size-dependent optical and electronic properties 
which make them highly desirable for fluorometric sensor 
applications, as wavelength emission bands can be precisely 
tuned by variation in size and composition. In addition to 
this tunable fluorescence, they have many other advanta-
geous properties when compared with other commonly used 
fluorescent labels. Their fluorescence is very bright, about 
10-20 folds brighter than organic fluorophores and emission 
signals are significantly resistant to photo bleaching, which 
in turn provides the ability to use multiple color staining, 
while maintaining high contrast between objects, such as 
organs. Another fundamental feature of QDs is the 
possession of broad absorption spectra while maintaining 
specific emission spectra, which allows for the use of 
multiple QDs that could have differential targets and 
fluoresce at different wavelengths but can use the same 
excitation light source [33].  
 There has not been a great deal of research done 
exploring the use of QDs for bacterial diagnostics but there 
have been some researches that have shown promise in the 
area. Firstly, a study conducted by Hahn [34] was aimed at 
being able to detect a single bacterial pathogen with 
semiconductor QDs. The experiment involved the use of a 
CdSe core with an outer shell of ZnS, this was then 
functionalized further to have a polymer coating with 
attached streptavidin and antibodies for targeting specific 
bacteria types. The bacteria targeted in this experiment were 
a strain of E. coli 0157:H7, so antibodies used to target the 
specific bacteria were used known as anti-E coli o157:H7. 
Observed results were impressive, boasting an increase in 
the sensitivity by 2 orders of magnitude over similar organic 
fluorophore. Even when a greater amount of the organic 
fluorophores were used they weren’t able to match the signal 
strength or match the detection limits of the functionalized 
QDs. Overall results showed that QDs were very stable as 
well as highly sensitive and being able to detect single 
bacterium, it should also be noted in this case that no protein 
function or QD emission was effected by cell labeling [35].  
 In another separate study conducted by Edgar [35]
 
they 
created a QD that is functionalized in almost the same way 
as mentioned in the previous study and it was also composed 
of a ZnS shell and coated with streptavidin. Although in 
addition, it also incorporated biotinylated bacteriophages to 
produce biotin-tagged phage quantum-dot nanocomplexes
 
(Fig. 2). Once the phage-QD complexes have bound with the 
bacteria it is possible to use any of microscopy, spectroscopy 
or flow cytometry to observe the bacteria. Due to the 
addition of biotin-phages with the quantum dot complexes it 
improves the signal amplification, while still maintaining 
highly specific targeting, due to the larger number of QDs on 
the targeting carrier. The results were impressive showing 
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enhanced detection of bacterial cells, in this case E. coli, but 
through the use of alternative phages it could be possible to 
detect a range of different bacterium species. The technique 
showed an improvement in sensitivity, observed results were 
able to detect as little as 10 cells of E. coli per milliliter 
within approximately 1 hour [36]. The results highlight the 
potential of using a highly sensitive detection system that 
could be used in a clinical environment, such as hand-held 
device that would be able to quickly and effectively detect 
pathogenic bacteria. In another more novel way of using 
QDs as a bacterial diagnostic agents conducted by 
Dwarakanath, works on the basis of a notable change in the 
emission spectra of QDs when bound to a bacteria by either 
aptamers or antibodies [36]. In the experiments conducted to 
research the phenomena of change in emission wavelength, 
it was shown to be independent of aptamers or antibody size. 
Sizes of aptamers and antibodies from 900 kDa down to as 
small as 18 kDa still exhibit a shift in the emission spectra. 
This study highlights the potential for a specific bacterial 
diagnostic system based on the shifts of emission spectra 
from QDs [37].  
 
Fig. (2). Labeling of bacteria cells with biotinylated anti-bacterial 
antibodies and streptavidin-conjugated CdSe/ZnS core/shell QDs. 
Dye-Doped Fluorescent Silica Nanoparticles 
 There are currently many silica nanoparticle based 
bioanalysis systems and all of which are different techniques 
and materials to alter the mode and purpose of the particles 
action. As stated above, there are a range of different Silica-
based nanoparticles, but for the purpose of this review it will 
be limited to the ones that have been researched in reference 
to bacterial diagnostics, just to note there is a great summary 
of most of the silica based nanoparticles being used in 
bioimaging in a review by Yan [38]. In this review it will be 
mainly focusing on the use of dye-doped silica nanoparticles 
will be mainly focussed, due to the fact that there has been a 
considerable amount of research conducted on them and that 
they have been observed to be quite effective. It should also 
be mentioned that although dye-doped silica nanoparticles 
are the same in principle but they can differ quite 
synthetically and in terms of results as well. Silica 
nanoparticles are used due their appropriate properties for 
the production of targeted bioimaging units. It was shown 
that they are also able to successfully trap dyes within the 
silica matrix, which in turn provides an effective barrier 
significantly reducing dye leakage. The reduction in dye 
leakage also means an improvement in the reduction of 
photobleaching and photodegradation, which enable their 
use for prolonged bioimaging and analysis work. Another 
feature that should be noted is the ability to functionalize the 
surface with relatively simple chemistry, as a range of 
functional groups can be added to add extra functionality by 
conjugation, such as a targeting ligand or a protecting 
molecule could be used for example. It has also been found 
in a study performed by Yao that the emission intensity of 
dye-doped silica NPs were equivalent to the use of 39 QD 
particles, which is due to the large packing number of dye 
molecules within the Silica NPs [39]. As mentioned 
previously, Silica nanoparticles are being used for a range of 
bioimaging and bioanalysis purposes although not a 
considerable amount was used in the detection of bacteria. In 
the study conducted by Yao they have created unique silica 
NPs which they entitled FloDots. They test the ability of 
bioconjugated FloDots as a means of rapid and specific 
determination of a single bacteria cell. In the experiment 
they used E.coli 0157:H7 as the target bacteria and use 
antibodies that target an antigen present on the surface of the 
bacteria. Results observed showed that it was possible to 
detect a single bacterium within 20 minutes and was 
confirmed by plate-counting method [39]. Wang [40]
 
also 
showed the dye-doped silica NPs could be used as a method 
of monitoring pathogenic bacteria, with high sensitivity and 
short amount of incubation time. In their study they 
employed multicolored FRET (fluorescence resonance 
energy transfer) silica NPs, which employs the use of using a 
ratio of three dyes encapsulated in the silica NPs to produce 
unique colors upon excitation. Three types of FRET NPs 
were produced with different ratios of the three dyes; they 
were also further conjugated with PEG-streptavidin-biotin-
IgG complex. Corresponding antibodies from one of the 
three species of bacteria were used as the targeting molecule; 
in this case they used the bacteria E. coli, S. aureus and 
Salmonella typhimurium. Now that the triple-dye-doped NPs 
have a specific antibody correlating only to one particular 
bacterium as well as each particle having its own alternative 
ratio of the three dyes, it was possible to match a particular 
color emission with a specific bacteria type. The three 
bacterial species were incubated for 30 min along with the 
three-antibody labeled NPs and when viewed under a 
confocal microscope it was observed that bacteria were 
covered with their specifically colored NPs corresponding to 
their antigen present on the surface of the bacteria. The study 
highlights the potential of such a multiplexed diagnostic 
system, which is able to quickly and accurately identify a 
particular bacteria, such a system could be applicable for 
commercial use and for diagnostic purposes in regards to 
human health and livestock [40]. 
Carbon Nanotubes 
 As mentioned previously, new carbon nanotube applica-
tions are continuously being discovered, as the unique 
properties are of high interest. Carbon nanotubes have been 
applied as diagnostic tools in a range of areas of medicine 
such as cancer and other human pathogens in vitro, but not 
much has been done in the way of bacterial diagnostics in 
vivo. A study to test the effectiveness of photothermal 
antimicrobial nanotherapy and nanodiagnostics using self-
assembling carbon nanotubes was performed by Kim [41]
 
and has shown as an effective method of being able to 
achieve both bacterial diagnosis and destruction. The study 
involved the use of dispersed and shortened carbon nano-
tubes (dsCNTs) and minimally treated carbon nanotubes 
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clusters that when in solution with bacteria are able to cluster 
at the bacterial surfaces or alternatively when using the CNT 
clusters which are able to form bacterial clusters. Once the 
bacterial or CNT clusters have formed they can be used to 
detect a single bacterium and or can be used to destroy the 
pathogenic bacteria. The process works by taking advantage 
of the responsiveness of carbon nanotubes to inherent near 
infrared lasers, which when targeted and applied causes 
observed bubbling phenomena that is able to completely 
destroy bacterial cells. Another advantage of this technique 
is due to the self-binding affinity of CNTs with bacteria it is 
unnecessary for any bioconjugation of targeting molecules, 
although if required for species specific purposes it is 
possible to do so. The study highlighted the potential appli-
cation of CNT with pulse lasers as effective photothermal 
contrast agents that are able to self-deliver to the bacterial 
infection site and could be applied in the detection of a 
single bacterial cell in real-time [41]. Another similar study 
has been completed which used the same techniques of 
photothermal carbon nanotubes but employs targeted gold 
nanoparticles to do the job, and was shown to be equally 
effective [42].  
LIMITATIONS OF NANOTECHNOLOGY 
 Nanomedicine, incarnation of the nanotechnology based 
concepts has the potential to fix innumerable problems 
especially in the field of medicine that remain a challenge till 
date, but like any other application of scientific advance-
ment, nanotechnology has its own limitations. Possible 
effects of this technology could be in terms of power budget 
concerns of human body, where our body system utilizes 
certain amount of energy for its metabolic activities. The 
nano based application for the treatment of health aliments 
include development of nanomotors or nanorobots that 
function at cellular level which can lead to energy utilization 
at least 10 times the normal range, therefore creating an 
energy imbalance. Nanoparticles systems, comprised of 
multiple components which are less than 100 nm. At this 
scale there is an extremely large volume to surface ratio that 
can manifest profound effects on the interactions of 
nanoscale devices with the biological counterparts. In vivo 
studies conducted on exposure of carbon nanotubes (CNT’s) 
resulted in inflammation and toxic side effects in lungs and 
cardiovascular systems of mice, the assessment of CNT on 
human keratinocytes have revealed the toxic side effects 
invitro [43]. Cerium dioxide nanoparticles used as a 
promising radio -, cardio -, and neuro - protectant showed 
geno toxicity in terms of DNA damage towards human 
dermal fibroblasts by generation of reactive oxygen species 
leading to an oxidative stress [44]. In vitro studies with poly 
(butylcyanoacrylate) nanoparticles coated with polysorbate 
80 cross the blood brain barrier via plasma adsorption of 
apolipoproteins resulting in receptor mediated endocytosis 
[45]. Nanoparticles are known to show increased toxicity 
due to their increased surface area. Nanoparticles 
formulations prepared from copper, cobalt, titanium oxide 
and silicon oxide had an inflammatory and toxic side effect 
on cells [46]. Engineering nanoparticles react with various 
components of immune system for instance, release of pro-
inflammatory and inflammatory cytokines, inflammogenic 
effects of cobalt and nickel nanoparticles, stimulation of 
TNF alpha secretion from macrophages by hydroxyapatite 
crystals that can lead to activation of phagocytes, generation 
of allergic mechanisms by carbon nanoparticles. Thus, 
nanoparticles have immunomodulatory potential that 
stimulate or suppress immune system which are undesirable 
effects in human body. Multiwalled carbon nanotubes 
suppress T cells in the immune system [47]. 
 Titanium dioxide/zinc oxide nanoparticles used in 
cosmetics are known to possess oxidative DNA damaging 
capacity in vitro and in cultured human fibroblasts. Exposure 
of skin to single walled carbon nanotubes caused dermal 
toxicity and morphological changes due to oxidative stress. 
In vitro studies conducted in mice and rats caused 
granulomas after exposure to carbon nanotubes. Crystalline 
silver nanoparticle – related cytotoxicity in lesioned skin, 
human fibroblasts and keratinocytes [48]. Engineered 
nanoparticles are known to posses major genotoxic effects 
such as interaction with DNA and non DNA targets, their 
interaction with components associated with cell growth 
cycle such as centromeres, cytoskeleton, microtubules etc 
induce polyploidy and aneugenic events during cell division. 
Some of the other possible effects of nanoparticles include 
Metal release, desorption of organic components, interaction 
with SH groups and Zn fingers of key proteins, saturation of 
metallothionein, changes in DNA methylation, secondary 
genotoxic effects through inflammation and activation of 
leukocytes, HIF stabilization through hypoxia-like effects, 
apoptosis/ necrosis and inhibition of key receptors/enzymes 
[49]. Although, various above discussed limitations and 
unforeseen problems that can arise from nanotechnology and 
its applications in medicine, its derivative technologies have 
a promising impact to solve more problems than they will 
create. 
CONCLUSION 
 Nanomedicine has provided new avenues for antibac-
terial therapeutics and diagnostics as well as enhancing 
current systems through the use of new novel nanomaterials. 
A variety of potential antibacterial therapeutics has been 
mentioned in the review from both synthetic and biologically 
inspired materials that have been engineered to a nanoscale. 
Quite a number of the therapeutics reviewed in this paper 
have been inspired from the bulk materials themselves such 
as silver and bioactive glasses, as there antibacterial activity 
was already recognized, but it was shown to be optimized 
when present in nanometric scales. High percentages of 
bacterial inhibition were demonstrated, and in some cases 
were found to completely inhibit growth of a variety of 
gram-negative and gram-positive bacteria species. Some of 
these developing techniques will find more success than 
others as it is only early days for all of the reviewed 
therapeutics, but if successful, will have a collection of uses 
such as ointments, sterilizing paints and materials, as well as 
the sterilization of medical equipments and clinical 
environments and have even showed a promise as potentially 
being applied in vivo medical therapeutics. 
 Also examined in the paper was the research performed 
in the area of potential bacterial diagnostic systems. With the 
research conducted through the optimization of functiona-
lized nanoparticles impressive results were able to be 
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obtained, exhibiting ultra sensitivity, rapid detection and 
beneficial properties for bioimaging, such as improved 
fluorescence. Best results showed that a single bacterium 
could be detected within a rapid time frame, as well as the 
use of multiple colored dyes to simultaneously detect three 
species of bacteria. A potential application for these new 
rapid and ultrasensitive bacterial diagnostics systems could 
be the ability to create a hand-held device capable of 
detecting a variety of bacteria species that the required can 
be used easily and quickly within the doctor’s office, so that 
treatment if needed can be administered as soon as possible.  
 As with most new researches there are a range of hurdles 
to overcome and antibacterial therapeutics and diagnostic 
medicine and nanomedicine are not exempted from this. As 
the nanomedicine itself is still in its infancy, a lot of 
researches into the safety and properties of nanotechnologies 
and materials still needs to be addressed. Other implications 
that need to be addressed include the improvement of surface 
modifications to nanomaterials, uniform synthesis of parti-
cles and other materials in terms of size and function, 
reducing the chance of non-specific binding, and preferably 
non-toxic and biocompatible. Although there are a number 
of hurdles to overcome these efforts remain high, but 
hopefully through the combination of these potential new 
antibacterial therapeutics and diagnostics, we will be able to 
successfully diagnose and destroy pathogenic bacteria.  
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